Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandra Mohan

Showing results (61-70 of 630) with videos related to

Pageof 63
Sort By:
Current Opinion in Rheumatology|January 11, 2022
Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insightsJulius Lindblom, Chandra Mohan, Ioannis Parodis
Arthritis Research & Therapy|May 15, 2022
Mobile health apps for systemic lupus erythematosus and lupus nephritis: a critical appraisalAkshara Ramasamy, Poojitha Dugyala, Chandra Mohan
Arthritis Research & Therapy|November 15, 2011
Lupus nephritis: current updateRamesh Saxena, Tina Mahajan, Chandra Mohan
Sexual Plant Reproduction|December 25, 2009
Cyclic pollen production in Cedrus deodaraVinod Prasad Khanduri, Chandra Mohan Sharma
Clinical Immunology (Orlando, Fla.)|July 21, 2007
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritisYuyang Fu, Yong Du, Chandra Mohan
Expert Opinion on Medical Diagnostics|March 19, 2013
Biomarkers of rheumatoid arthritis: recent progressTianfu Wu, Deena Sajitharan, Chandra Mohan
Archivum Immunologiae Et Therapiae Experimentalis|February 6, 2008
Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritisYong Du, Yuyang Fu, Chandra Mohan
Molecular Immunology|October 18, 2003
Molecular signatures of anti-nuclear antibodies--contribution of heavy chain framework residuesPeter Sedrak, Kelvin Hsu, Chandra Mohan
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Molecular signatures of anti-nuclear antibodies: contributions of specific light chain residues and a novel New Zealand Black V kappa 1 germline geneZhiyan Liang, Cui Chen, Chandra Mohan
Nutrients|May 5, 2019
Curcumin in Autoimmune and Rheumatic DiseasesMelissa Yang, Umair Akbar, Chandra Mohan
Pageof 63

Showing results (61-70 of 630) with videos related to

Sort By:
Pageof 63
Current Opinion in Rheumatology|January 11, 2022
Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insightsJulius Lindblom, Chandra Mohan, Ioannis Parodis
Arthritis Research & Therapy|May 15, 2022
Mobile health apps for systemic lupus erythematosus and lupus nephritis: a critical appraisalAkshara Ramasamy, Poojitha Dugyala, Chandra Mohan
Arthritis Research & Therapy|November 15, 2011
Lupus nephritis: current updateRamesh Saxena, Tina Mahajan, Chandra Mohan
Sexual Plant Reproduction|December 25, 2009
Cyclic pollen production in Cedrus deodaraVinod Prasad Khanduri, Chandra Mohan Sharma
Clinical Immunology (Orlando, Fla.)|July 21, 2007
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritisYuyang Fu, Yong Du, Chandra Mohan
Expert Opinion on Medical Diagnostics|March 19, 2013
Biomarkers of rheumatoid arthritis: recent progressTianfu Wu, Deena Sajitharan, Chandra Mohan
Archivum Immunologiae Et Therapiae Experimentalis|February 6, 2008
Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritisYong Du, Yuyang Fu, Chandra Mohan
Molecular Immunology|October 18, 2003
Molecular signatures of anti-nuclear antibodies--contribution of heavy chain framework residuesPeter Sedrak, Kelvin Hsu, Chandra Mohan
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Molecular signatures of anti-nuclear antibodies: contributions of specific light chain residues and a novel New Zealand Black V kappa 1 germline geneZhiyan Liang, Cui Chen, Chandra Mohan
Nutrients|May 5, 2019
Curcumin in Autoimmune and Rheumatic DiseasesMelissa Yang, Umair Akbar, Chandra Mohan
Pageof 63